Kurs
+0,66%
Likviditet
12,0 MEUR
Kalender
Est. tid* | ||
2025-10-28 | 11:00 | Kvartalsrapport 2025-Q3 |
2025-10-15 | N/A | X-dag halvårsutdelning ORNAV 0.82 |
2025-10-15 | N/A | X-dag halvårsutdelning ORNBV 0.82 |
2025-07-18 | 11:00 | Kvartalsrapport 2025-Q2 |
2025-04-23 | 11:00 | Kvartalsrapport 2025-Q1 |
2025-04-04 | N/A | X-dag halvårsutdelning ORNBV 0.82 |
2025-04-04 | N/A | X-dag halvårsutdelning ORNAV 0.82 |
2025-04-03 | N/A | Årsstämma |
2025-02-25 | - | Bokslutskommuniké 2024 |
2024-10-29 | - | Kvartalsrapport 2024-Q3 |
2024-10-15 | - | X-dag halvårsutdelning ORNBV 0.81 |
2024-10-15 | - | X-dag halvårsutdelning ORNAV 0.81 |
2024-08-08 | - | Kvartalsrapport 2024-Q2 |
2024-04-25 | - | Kvartalsrapport 2024-Q1 |
2024-03-21 | - | X-dag halvårsutdelning ORNBV 0.81 |
2024-03-21 | - | X-dag halvårsutdelning ORNAV 0.81 |
2024-03-20 | - | Årsstämma |
2024-02-13 | - | Bokslutskommuniké 2023 |
2023-10-26 | - | Kvartalsrapport 2023-Q3 |
2023-07-17 | - | Kvartalsrapport 2023-Q2 |
2023-04-27 | - | Kvartalsrapport 2023-Q1 |
2023-03-23 | - | X-dag ordinarie utdelning ORNBV 1.60 EUR |
2023-03-23 | - | X-dag ordinarie utdelning ORNAV 1.60 EUR |
2023-03-22 | - | Årsstämma |
2023-02-09 | - | Bokslutskommuniké 2022 |
2022-10-20 | - | Kvartalsrapport 2022-Q3 |
2022-07-15 | - | Kvartalsrapport 2022-Q2 |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-03-24 | - | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2022-03-24 | - | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2022-03-23 | - | Årsstämma |
2022-02-10 | - | Bokslutskommuniké 2021 |
2021-10-20 | - | Kvartalsrapport 2021-Q3 |
2021-07-19 | - | Kvartalsrapport 2021-Q2 |
2021-04-27 | - | Kvartalsrapport 2021-Q1 |
2021-03-26 | - | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2021-03-26 | - | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2021-03-25 | - | Årsstämma |
2021-02-09 | - | Bokslutskommuniké 2020 |
2020-10-21 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-05-07 | - | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2020-05-07 | - | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2020-05-06 | - | Årsstämma |
2020-04-28 | - | Kvartalsrapport 2020-Q1 |
2020-03-26 | - | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2020-02-05 | - | Bokslutskommuniké 2019 |
2019-10-23 | - | Kvartalsrapport 2019-Q3 |
2019-07-17 | - | Kvartalsrapport 2019-Q2 |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-03-27 | - | X-dag ordinarie utdelning ORNBV 1.50 EUR |
2019-03-27 | - | X-dag ordinarie utdelning ORNAV 1.50 EUR |
2019-03-26 | - | Årsstämma |
2019-02-06 | - | Bokslutskommuniké 2018 |
2018-10-24 | - | Kvartalsrapport 2018-Q3 |
2018-07-18 | - | Kvartalsrapport 2018-Q2 |
2018-04-24 | - | Kvartalsrapport 2018-Q1 |
2018-03-21 | - | X-dag ordinarie utdelning ORNBV 1.45 EUR |
2018-03-21 | - | X-dag ordinarie utdelning ORNAV 1.45 EUR |
2018-03-20 | - | Årsstämma |
2018-02-07 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-07-19 | - | Kvartalsrapport 2017-Q2 |
2017-05-18 | - | Kapitalmarknadsdag 2017 |
2017-04-26 | - | Kvartalsrapport 2017-Q1 |
2017-03-23 | - | X-dag bonusutdelning ORNAV 0.2 |
2017-03-23 | - | X-dag ordinarie utdelning ORNAV 1.35 EUR |
2017-03-23 | - | X-dag bonusutdelning ORNBV 0.2 |
2017-03-23 | - | X-dag ordinarie utdelning ORNBV 1.35 EUR |
2017-03-22 | - | Årsstämma |
2017-02-08 | - | Bokslutskommuniké 2016 |
2016-10-25 | - | Kvartalsrapport 2016-Q3 |
2016-07-19 | - | Kvartalsrapport 2016-Q2 |
2016-04-27 | - | Kvartalsrapport 2016-Q1 |
2016-03-23 | - | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2016-03-23 | - | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2016-03-22 | - | Årsstämma |
2016-02-02 | - | Bokslutskommuniké 2015 |
2015-10-27 | - | Kvartalsrapport 2015-Q3 |
2015-07-28 | - | Kvartalsrapport 2015-Q2 |
2015-05-26 | - | Kapitalmarknadsdag 2015 |
2015-04-29 | - | Kvartalsrapport 2015-Q1 |
2015-03-25 | - | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2015-03-25 | - | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2015-03-24 | - | Årsstämma |
2015-02-04 | - | Bokslutskommuniké 2014 |
2014-10-21 | - | Kvartalsrapport 2014-Q3 |
2014-07-29 | - | Kvartalsrapport 2014-Q2 |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-03-26 | - | X-dag ordinarie utdelning ORNBV 1.25 EUR |
2014-03-26 | - | X-dag ordinarie utdelning ORNAV 1.25 EUR |
2014-03-25 | - | Årsstämma |
2014-02-04 | - | Bokslutskommuniké 2013 |
2013-10-22 | - | Kvartalsrapport 2013-Q3 |
2013-07-30 | - | Kvartalsrapport 2013-Q2 |
2013-04-23 | - | Kvartalsrapport 2013-Q1 |
2013-03-20 | - | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2013-03-20 | - | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2013-03-19 | - | Årsstämma |
2013-02-05 | - | Bokslutskommuniké 2012 |
2012-10-23 | - | Kvartalsrapport 2012-Q3 |
2012-07-31 | - | Kvartalsrapport 2012-Q2 |
2012-05-24 | - | Kapitalmarknadsdag 2012 |
2012-04-24 | - | Kvartalsrapport 2012-Q1 |
2012-03-21 | - | X-dag bonusutdelning ORNAV 0.12 |
2012-03-21 | - | X-dag ordinarie utdelning ORNAV 1.30 EUR |
2012-03-21 | - | X-dag bonusutdelning ORNBV 0.12 |
2012-03-21 | - | X-dag ordinarie utdelning ORNBV 1.30 EUR |
2012-03-20 | - | Årsstämma |
2012-02-07 | - | Bokslutskommuniké 2011 |
2011-10-25 | - | Kvartalsrapport 2011-Q3 |
2011-08-02 | - | Kvartalsrapport 2011-Q2 |
2011-04-27 | - | Kvartalsrapport 2011-Q1 |
2011-04-01 | - | X-dag bonusutdelning ORNBV 0.06 |
2011-04-01 | - | X-dag ordinarie utdelning ORNBV 1.20 EUR |
2011-04-01 | - | X-dag bonusutdelning ORNAV 0.06 |
2011-04-01 | - | X-dag ordinarie utdelning ORNAV 1.20 EUR |
2011-03-31 | - | Årsstämma |
2011-02-09 | - | Bokslutskommuniké 2010 |
2010-10-26 | - | Kvartalsrapport 2010-Q3 |
2010-08-10 | - | Kvartalsrapport 2010-Q2 |
2010-04-27 | - | Kvartalsrapport 2010-Q1 |
2010-03-25 | - | X-dag bonusutdelning ORNBV 0.1 |
2010-03-25 | - | X-dag ordinarie utdelning ORNBV 1.00 EUR |
2010-03-25 | - | X-dag bonusutdelning ORNAV 0.1 |
2010-03-25 | - | X-dag ordinarie utdelning ORNAV 1.00 EUR |
2009-03-24 | - | X-dag ordinarie utdelning ORNBV 0.95 EUR |
2009-03-24 | - | X-dag ordinarie utdelning ORNAV 0.95 EUR |
2008-03-26 | - | X-dag ordinarie utdelning ORNBV 1.00 EUR |
2007-04-03 | - | X-dag ordinarie utdelning ORNBV 1.00 EUR |
2007-04-03 | - | X-dag ordinarie utdelning ORNAV 1.00 EUR |
2006-03-22 | - | X-dag ordinarie utdelning ORNBV 0.85 EUR |
2005-03-22 | - | X-dag ordinarie utdelning ORNBV 0.55 EUR |
2005-03-22 | - | X-dag ordinarie utdelning ORNAV 0.55 EUR |
2004-09-15 | - | X-dag bonusutdelning ORNBV 2.14 |
2004-09-15 | - | X-dag bonusutdelning ORNAV 2.14 |
2004-03-23 | - | X-dag ordinarie utdelning ORNBV 1.60 EUR |
2004-03-23 | - | X-dag ordinarie utdelning ORNAV 1.60 EUR |
2003-12-12 | - | X-dag bonusutdelning ORNBV 1.5 |
2003-12-12 | - | X-dag bonusutdelning ORNAV 1.5 |
2003-03-23 | - | X-dag ordinarie utdelning ORNAV 0.93 EUR |
2003-03-23 | - | X-dag ordinarie utdelning ORNBV 0.93 EUR |
2002-04-16 | - | X-dag ordinarie utdelning ORNBV 1.10 EUR |
2002-04-16 | - | X-dag ordinarie utdelning ORNAV 1.10 EUR |
2001-03-30 | - | X-dag ordinarie utdelning ORNBV 1.20 EUR |
2001-03-30 | - | X-dag ordinarie utdelning ORNAV 1.20 EUR |
2000-03-31 | - | X-dag ordinarie utdelning ORNBV 1.18 EUR |
2000-03-31 | - | X-dag ordinarie utdelning ORNAV 1.18 EUR |
1999-07-28 | - | X-dag bonusutdelning ORNBV 13.46 |
1999-07-28 | - | X-dag bonusutdelning ORNAV 13.46 |
1999-04-09 | - | X-dag ordinarie utdelning ORNBV 6.50 EUR |
1999-04-09 | - | X-dag ordinarie utdelning ORNAV 6.50 EUR |
1998-04-21 | - | X-dag ordinarie utdelning ORNBV 7.50 EUR |
1998-04-21 | - | X-dag ordinarie utdelning ORNAV 7.50 EUR |
1997-04-22 | - | X-dag ordinarie utdelning ORNBV 5.00 EUR |
1997-04-22 | - | X-dag ordinarie utdelning ORNAV 5.00 EUR |
1996-04-23 | - | X-dag ordinarie utdelning ORNBV 4.00 EUR |
1996-04-23 | - | X-dag ordinarie utdelning ORNAV 4.00 EUR |
Beskrivning
Land | Finland |
---|---|
Lista | Large Cap Helsinki |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
ORION CORPORATION
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS
3 March 2025 at 16.30 EET
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 28 February 2025 above five (5) per cent of Orion Corporation’s total shares.
Total positions of BlackRock, Inc. and its funds subject to notification:
% of shares and voting rights (total of point A) | % of shares and voting rights through financial instruments (total of point B) | Total of both in % (points A + B) | Total number of shares and voting rights of issuer | |
Resulting situation on the date on which threshold was crossed or reached | 4.98% shares Below 5% voting rights | 0.01% shares Below 5% voting rights | 5.00% shares Below 5% voting rights | 141,134,278 shares 763,427,275 voting rights |
Position of previous notification (if applicable) | Below 5% shares Below 5% voting rights | Below 5% shares Below 5% voting rights | Below 5% shares Below 5% voting rights |
Notified details of the resulting situation on the date on which the threshold was crossed:
Point A: Shares and voting rights:
Class/type of shares ISIN code | Number of shares and voting rights | % of shares and voting rights | ||
Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | |
FI0009014377 | 7,042,164 shares Below 5% voting rights | 4.98% shares Below 5% voting rights | ||
POINT A SUBTOTAL | 7,042,164 shares Below 5% voting rights | 4.98% shares Below 5% voting rights |
Point B: Financial instruments according to SMA 9:6a:
Type of financial instrument | Expiration date | Exercise / Conversion Period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
Securities Lent | N/A | N/A | Physical | 15,741 shares Below 5% voting rights | |
POINT B SUBTOTAL |
Orion Corporation
Liisa Hurme President and CEO | Olli Huotari EVP, Corporate Functions |
Contact person:
Tuukka Hirvonen, Investor Relations, Orion Corporation
tel. +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orionpharma.com
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2024 amounted to EUR 1,542 million and the company had about 3,700 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.